Original Research
Published on 20 Sep 2022
Distinct mechanism of cervical cancer cell death caused by the investigational new drug SHetA2
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.958536
- 1,979 views
Type at least 3 characters
678 articles
Articles
Original Research
Published on 20 Sep 2022
The burden of cervical cancer in China
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.979809
- 3,181 views
- 4 citations
Original Research
Published on 20 Sep 2022
Impact of examined lymph node number on lymph node status and prognosis in FIGO stage IB-IIA cervical squamous cell carcinoma: A population-based study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.994105
- 988 views
- 2 citations
Original Research
Published on 16 Sep 2022
Impact of perioperative red blood cell transfusion, anemia of cancer and global health status on the prognosis of elderly patients with endometrial and ovarian cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.967421
- 3,876 views
- 4 citations
Original Research
Published on 16 Sep 2022
Performance of the IOTA ADNEX model combined with HE4 for identifying early-stage ovarian cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.949766
- 2,680 views
- 4 citations
Original Research
Published on 16 Sep 2022
The Impact of Malignancy on Assisted Reproductive Outcomes for Cancer Survivors: A Retrospective Case–Control Study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.941797
- 1,602 views
Original Research
Published on 16 Sep 2022
Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1011000
- 1,519 views
- 3 citations
Systematic Review
Published on 16 Sep 2022
Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.965029
- 2,519 views
- 5 citations
Review
Published on 15 Sep 2022
Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy — non-mitotic mechanisms of paclitaxel
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.907520
- 3,088 views
- 3 citations
Original Research
Published on 15 Sep 2022
Construction of a prognostic signature for serous ovarian cancer based on lactate metabolism-related genes
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.967342
- 2,554 views
- 4 citations
Case Report
Published on 14 Sep 2022
Primary squamous cell carcinoma of the ovary. Review of the literature
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.962613
- 3,032 views
- 1 citation
Original Research
Published on 14 Sep 2022
Single cell sequencing analysis and transcriptome analysis constructed the liquid-liquid phase separation(LLPS)-related prognostic model for endometrial cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1005472
- 2,467 views
- 1 citation
Original Research
Published on 14 Sep 2022
Absence of high-grade cervical intraepithelial neoplasia in conization specimens from patients with colposcopic biopsy-confirmed high-grade cervical intraepithelial neoplasia: Retrospective study of 1695 cases
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.980884
- 858 views
- 2 citations
Case Report
Published on 14 Sep 2022
Breast metastasis of cervical cancer: A case report and systematic literature review
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.974592
- 2,087 views
Original Research
Published on 12 Sep 2022
Amide proton transfer weighted imaging combined with dynamic contrast-enhanced MRI in predicting lymphovascular space invasion and deep stromal invasion of IB1-IIA1 cervical cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.916846
- 1,716 views
- 2 citations
Original Research
Published on 09 Sep 2022
Preoperative CT-based deep learning model for predicting overall survival in patients with high-grade serous ovarian cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.986089
- 2,817 views